CompaniesADvantage Therapeutics

ADvantage Therapeutics

active

Miami, FL, United States

Founded 2021

About

Alzheimer's Treatments

Areas of Focus

Categories

Small Molecule PharmaceuticalSoutheastern U.S.

Team (15)

Achim Schneeberger, M.D.

ADvantage Therapeutics

Bruno Dubois, M.D.

ADvantage Therapeutics

Carmela Abraham, Ph.D.

ADvantage Therapeutics

Cynthia A. Lemere, Ph.D.

ADvantage Therapeutics

David Buchsbaum

ADvantage Therapeutics

Jeffrey B. Madden

ADvantage Therapeutics

View all 15 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

122

By Phase

PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

2027

2028

Today

Hover over trial bars to see details

Recent Trials

NCT07107074Lead Sponsor

Effects of a Widely Used Vaccine Adjuvant in Subjects With Early Alzheimer's Disease Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE

PHASE2Active, not recruiting

122 participants

Started: Nov 8, 2023 · Completed: Jul 31, 2027

Funding History (4)

D/A

Jul 28, 2025

D

Jul 12, 2023

D

Jun 15, 2022

D

Jun 24, 2021

Locations (1)

Headquarters

Miami, FL, United States

Map

Loading map...